Shree Ganesh Remedies to migrate to BSE main board
The Board of Directors at Shree Ganesh Remedies considered and approved the migration of the company listing to the main board of BSE.
Company : Shree Ganesh Remedies Ltd
Board of Directors at Shree Ganesh Remedies considered and approved the migration of the company listing from BSE SME platform to the main board of Bombay Stock Exchange.
In August, 2017, Shree Ganesh Remedies issued 23.76 lacs equity shares at the value of Rs.36 per equity share, (face value of Rs. 10 each and premium of Rs. 26 per equity share) aggregating to Rs. 855.36 lacs.
The IPO opened on September 28, 2017, and closed on October 05, 2017.
Shree Ganesh Remedies is the pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products (Drug Intermediates & Pharmaceuticals) in 1991.
Recent Stories